ARK Innovation ETF (ARKK) Dividend History

Dividend Yield: 1.02%

Dividend Frequency: Annually

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
December 31, 2021	$0.78	12/29/2021	12/30/2021
December 31, 2020	$2.04	12/29/2020	12/30/2020
December 31, 2019	$0.19	12/27/2019	12/30/2019
December 31, 2018	$0.08	12/27/2018	12/28/2018
December 31, 2018	$1.09	12/27/2018	12/28/2018
December 29, 2017	$0.35	12/27/2017	12/28/2017
December 29, 2017	$0.05	12/27/2017	12/28/2017
December 29, 2017	$0.09	12/27/2017	12/28/2017
December 31, 2015	$0.47	12/24/2015	12/29/2015

Dividends Summary

ARK Innovation ETF has issued 9 dividend payments over the past 6 years
The most recent dividend was paid 1300 days ago, on December 31, 2021
The first recorded dividend was paid on December 31, 2015
The highest dividend payout was $2.04 per share
The average dividend over this 6 year span is $0.57 per share
ARK Innovation ETF has increased its dividend payments by 68.26% since 2015

Company News

Elon Musk Is The 'Most Productive Human Being On Earth,' Says Ark Invest's Cathie Wood: 'Facts Are Facts'

Cathie Wood of Ark Invest praised Elon Musk as the 'most productive human being on earth', highlighting his achievements across multiple complex technology companies like Tesla and SpaceX.

Benzinga
1 Top Vanguard ETF to Buy Right Now

The Vanguard Value Index Fund ETF (VTV) is a good option for investors looking for stability in volatile markets. It invests in value stocks, which are less risky than growth stocks, and has a diversified portfolio with limited exposure to any one stock. While it has underperformed the broader S&P 500 index in recent years, it could outperform as investors rotate towards value-oriented stocks.

The Motley Fool

Featured Companies: BRK.A BRK.B JPM VTV
Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones

Umoja Biopharma, a clinical-stage biotechnology company, has closed a $100 million Series C financing to advance its in vivo CAR T cell therapy pipeline, including its lead CD22 UB-VV400 program in multiple oncology and autoimmune clinical studies.

GlobeNewswire Inc.
Is the ARKK Fund Ready to Play Nice?

The article discusses the recent performance of Cathie Wood's ARKK fund, which has seen some positive signs after a period of underperformance. The fund has increased its position in Tesla, and has cleared a key technical level, suggesting it may be ready to play a more prominent role in the market.

Investing.com

Featured Companies: TSLA
ETFs in Focus Post Tesla's Mixed Q2 Results - Zacks Investment Research

Tesla reported lower-than-expected Q2 2024 earnings, continuing its losing earnings streak for the fourth consecutive quarter. However, the company surpassed revenue estimates. This has impacted ETFs with significant Tesla exposure, including PP, XLY, VCAR, ARKK, and ARKQ.

Zacks Investment Research

Featured Companies: ARKQ TSLA XLY

Page data last updated 07/23/2025 07:53:39 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included